Correlation Between Walmart and Aceragen
Can any of the company-specific risk be diversified away by investing in both Walmart and Aceragen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walmart and Aceragen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walmart and Aceragen, you can compare the effects of market volatilities on Walmart and Aceragen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walmart with a short position of Aceragen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walmart and Aceragen.
Diversification Opportunities for Walmart and Aceragen
Excellent diversification
The 3 months correlation between Walmart and Aceragen is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Walmart and Aceragen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aceragen and Walmart is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walmart are associated (or correlated) with Aceragen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aceragen has no effect on the direction of Walmart i.e., Walmart and Aceragen go up and down completely randomly.
Pair Corralation between Walmart and Aceragen
If you would invest 7,724 in Walmart on September 4, 2024 and sell it today you would earn a total of 1,540 from holding Walmart or generate 19.94% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Walmart vs. Aceragen
Performance |
Timeline |
Walmart |
Aceragen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Walmart and Aceragen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Walmart and Aceragen
The main advantage of trading using opposite Walmart and Aceragen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walmart position performs unexpectedly, Aceragen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aceragen will offset losses from the drop in Aceragen's long position.Walmart vs. Aquagold International | Walmart vs. Thrivent High Yield | Walmart vs. Morningstar Unconstrained Allocation | Walmart vs. Via Renewables |
Aceragen vs. Addex Therapeutics | Aceragen vs. Soligenix | Aceragen vs. Avenue Therapeutics | Aceragen vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements |